Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KDM5A suppresses PML-RARα target gene expression and APL differentiation through repressing H3K4me2
Siyuan Xu, Siqing Wang, Shenghui Xing, et al.
Blood Advances (2021) Vol. 5, Iss. 17, pp. 3241-3253
Open Access | Times Cited: 19

Showing 19 citing articles:

Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 159
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
Ailin Zhao, Hui Zhou, Jinrong Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
JMJD family proteins in cancer and inflammation
Manni Wang, Jianxin Xue, Weiqi Hong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 54
Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation inIDH-Mutant Cancers
Kathryn Gunn, Matti Myllykoski, John Z. Cao, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1478-1497
Open Access | Times Cited: 23
Decoding the neurotoxic effects of propofol: insights into the RARα-Snhg1-Bdnf regulatory cascade
Yuhai Xu, Xin Xin, Tianzhu Tao
AJP Cell Physiology (2024) Vol. 326, Iss. 6, pp. C1735-C1752
Open Access | Times Cited: 5
Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
Yasuyo Ohguchi, Hiroto Ohguchi
Cancers (2022) Vol. 14, Iss. 13, pp. 3270-3270
Open Access | Times Cited: 17
Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China
Junnan Li, Pei Li, Simin Liang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 9332-9350
Open Access | Times Cited: 6
The JMJD family of histone demethylase and their intimate links to cardiovascular disease
Jiarun Xie, Haoyu Lin, Anna Zuo, et al.
Cellular Signalling (2024) Vol. 116, pp. 111046-111046
Closed Access | Times Cited: 2
Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies
Zsuzsanna Gaál
Biomolecules (2022) Vol. 13, Iss. 1, pp. 61-61
Open Access | Times Cited: 8
Molecular and epigenetic alterations in normal and malignant myelopoiesis in human leukemia 60 (HL60) promyelocytic cell line model
Jhinuk Basu, Swati Madhulika, Krushna Chandra Murmu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 4
Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer
Tian Guan, Yingshuang Zhang, Li Shen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116494-116494
Closed Access | Times Cited: 1
Domain architecture and protein–protein interactions regulate KDM5A recruitment to the chromatin
A. K. Kataria, Shweta Tyagi
Epigenetics (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Alterations of histone modifications in cancer
Maha Saber-Ayad, Wafaa S. Ramadan, Raafat El‐Awady
Elsevier eBooks (2023), pp. 85-172
Closed Access | Times Cited: 3
KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic
Shang‐Min Zhang, Jian Cao, Qin Yan
Advances in experimental medicine and biology (2023), pp. 113-137
Closed Access | Times Cited: 1
PML‐mediated nuclear loosening permits immunomodulation of mesenchymal stem/stromal cells under inflammatory conditions
Yunpeng Chu, Zishan Jiang, Zheng Gong, et al.
Cell Proliferation (2023) Vol. 57, Iss. 4
Open Access | Times Cited: 1
Ultrasensitive detection of genetic variation based on dual signal amplification assisted by isothermal amplification and cobalt oxyhydroxide nanosheets/quantum dots
Chenlan Shen, Tong Wang, Ke Yang, et al.
Microchimica Acta (2023) Vol. 191, Iss. 1
Closed Access | Times Cited: 1
Critical role of MXRA7 in differentiation blockade in human acute promyelocytic leukemia cells
Zhenjiang Sun, Dandan Lin, Ying Shen, et al.
Experimental Hematology (2023) Vol. 125-126, pp. 45-54
Open Access | Times Cited: 1
m6Acancer-Net: Identification of m6A-mediated cancer driver genes from gene-site heterogeneous network
Qianqian Ma, Shao‐Wu Zhang, Song-Yao Zhang
Methods (2022) Vol. 203, pp. 125-138
Closed Access | Times Cited: 1
Page 1

Scroll to top